Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Check for publication integrity before misconduct.

Literature DB >> 31911697

Check for publication integrity before misconduct.

Andrew Grey, Mark J Bolland, Alison Avenell, Andrew A Klein, C K Gunsalus.

Abstract

Keywords: Ethics; Institutions; Publishing; Research data

Mesh：

Year: 2020 PMID： 31911697 DOI： 10.1038/d41586-019-03959-6

Source DB: PubMed Journal: Nature ISSN： 0028-0836 Impact factor: 49.962

× No keyword cloud information.

10 in total

1. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.

Authors: C E Clarke
Journal: J Neurol Neurosurg Psychiatry Date: 2004-03 Impact factor: 10.154

2. Scientific misconduct: a new approach to prevention.

Authors: Magne Nylenna; Sigmund Simonsen
Journal: Lancet Date: 2006-06-10 Impact factor: 79.321

3. Risedronate for the prevention of hip fractures: concern about validity of trials.

Authors: Jutta Martha Halbekath; Stefanie Schenk; Andreas von Maxen; Gabriele Meyer; Ingrid Mühlhauser
Journal: Arch Intern Med Date: 2007-03-12

4. Substandard studies or substandard "standard-of-care".

Authors: Nuala Caffrey; Miriam Casey; Bernard Walsh
Journal: J Bone Miner Res Date: 2006-03 Impact factor: 6.741

5. Evidence for non-random sampling in randomised, controlled trials by Yuhji Saitoh.

Authors: J B Carlisle; J A Loadsman
Journal: Anaesthesia Date: 2017-01 Impact factor: 6.955

6. Statistics and the detection of scientific misconduct.

Authors: Robert A Gross
Journal: Neurology Date: 2016-11-09 Impact factor: 9.910

Review 7. Systematic review and statistical analysis of the integrity of 33 randomized controlled trials.

Authors: Mark J Bolland; Alison Avenell; Greg D Gamble; Andrew Grey
Journal: Neurology Date: 2016-11-09 Impact factor: 9.910

8. Quality of reports of investigations of research integrity by academic institutions.

Authors: Andrew Grey; Mark Bolland; Greg Gamble; Alison Avenell
Journal: Res Integr Peer Rev Date: 2019-02-19

9. Why has the number of scientific retractions increased?

Authors: R Grant Steen; Arturo Casadevall; Ferric C Fang
Journal: PLoS One Date: 2013-07-08 Impact factor: 3.240

10. An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature.

Authors: Alison Avenell; Fiona Stewart; Andrew Grey; Greg Gamble; Mark Bolland
Journal: BMJ Open Date: 2019-10-30 Impact factor: 2.692

10 in total

8 in total

Check for publication integrity before misconduct.

1. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.

2. Scientific misconduct: a new approach to prevention.

3. Risedronate for the prevention of hip fractures: concern about validity of trials.

4. Substandard studies or substandard "standard-of-care".

5. Evidence for non-random sampling in randomised, controlled trials by Yuhji Saitoh.

6. Statistics and the detection of scientific misconduct.

Review 7. Systematic review and statistical analysis of the integrity of 33 randomized controlled trials.

8. Quality of reports of investigations of research integrity by academic institutions.

9. Why has the number of scientific retractions increased?

10. An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature.

Review 1. A review of the current concerns about misconduct in medical sciences publications and the consequences.

Review 2. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Review 3. Ivermectin for preventing and treating COVID-19.

Review 4. Challenges in Interpreting Obstetrics and Gynecology Literature.

5. On the road to make KJA's review process robust, transparent, and credible: retracted study in systematic review.

Review 6. Ivermectin and the Integrity of Healthcare Evidence During COVID-19.

7. Deceiving scientific research, misconduct events are possibly a more common practice than foreseen.

8. Internal replication of computational workflows in scientific research.